Search

The integration of artificial intelligence (AI) into healthcare systems marked a pivotal evolution in clinical analytics architectures and governance structures, transforming data-driven decision-making from siloed, retrospective analyses to dynamic, predictive, and integrated frameworks. This period witnessed rapid advancements in machine learning (ML) applications for healthcare infrastructure, encompassing electronic health records (EHRs), imaging diagnostics, population health management, and real-time monitoring systems. Key developments included the shift toward federated learning to address data privacy concerns, the emergence of explainable AI (XAI) to enhance clinical trustworthiness, and the standardization of regulatory pathways for AI as medical devices. Architecturally, healthcare systems evolved from static analytics pipelines—where data ingestion, model training, and inference occurred in isolated phases—to adaptive, closed-loop configurations that incorporate feedback mechanisms for continuous model refinement and human-AI collaboration. Governance structures are adapted accordingly, emphasizing ethical frameworks to mitigate bias, ensure data equity, and promote algorithmic accountability, particularly for underserved populations. This review synthesizes literature from this timeframe, highlighting how AI-enabled analytics architectures facilitated precision medicine by integrating multimodal data sources, such as genomics, wearables, and social determinants of health, into cohesive systems. Challenges in interoperability and scalability were addressed through consensus guidelines like CONSORT-AI and SPIRIT-AI, which promoted transparent reporting of AI interventions in clinical trials. Moreover, the COVID-19 pandemic accelerated AI deployment in pandemic response systems, underscoring the need for resilient architectures capable of handling real-time data surges and uncertainty communication. Governance evolved to include multi-stakeholder perspectives, from regulatory bodies such as the FDA to clinical practitioners, ensuring that AI tools align with evidence-based medicine. This narrative review provides an original systems-level framing, organizing the literature around data-to-decision cycles, infrastructural integration, and governance maturation. By examining cross-study insights, it reveals how AI has fostered intelligent healthcare ecosystems, reducing diagnostic bias across diverse cohorts and enhancing decision support without over-relying on black-box models. Ultimately, this synthesis underscores the transition from AI as a supplementary tool to a foundational element of healthcare systems, paving the way for equitable, efficient clinical analytics.

Sepsis remains a major cause of mortality in intensive care units worldwide, with an estimated 49 million cases and over 11 million deaths annually, highlighting the need for earlier detection to improve outcomes. This systematic review synthesizes evidence on machine learning models for early sepsis prediction in adult ICU patients from 2017 to 2021, focusing on prediction horizons, data modalities, and validation approaches. A comprehensive search of PubMed, Embase, IEEE Xplore, ACM Digital Library, and arXiv identified studies meeting criteria for ICU-based sepsis prediction with at least a 4-hour forecast window, following PRISMA guidelines. Of 1,478 records screened, 35 studies were included, with prediction horizons ranging from 4 to 24 hours and most relying on hourly vital sign data and internal validation. Reported performance varied widely depending on horizon length, data sampling, and validation rigor, with external validation generally producing lower but more realistic results. Overall, while machine learning models show promising predictive ability, limitations in generalizability and standardization remain, emphasizing the need for stronger validation frameworks and reporting practices to support clinical translation.

Patient no-shows in outpatient clinics (5%–30% across specialties) disrupt scheduling efficiency, increase wait times, and strain healthcare resources. To address this, healthcare systems are increasingly applying machine learning (ML) for predictive scheduling support. This systematic review synthesizes ML approaches for predicting outpatient no-shows, focusing on model types, feature usage, and reported operational deployment outcomes, with emphasis on translation into clinical scheduling practice. A PRISMA-compliant search of PubMed, Embase, IEEE Xplore, Scopus, and Web of Science identified studies using ML for no-show prediction in outpatient settings. Data on models, features, performance, and implementation were extracted. Risk of bias was assessed using an adapted PROBAST tool. Thirty-two studies were included. Logistic regression, random forest, and XGBoost were the most commonly used models. Historical attendance data was the dominant predictive feature. Fewer than 20% of studies reported real-world implementation, and reported intervention outcomes (e.g., overbooking, reminders) were inconsistent. While ML models show strong predictive performance, real-world deployment and evidence of operational impact remain limited. This gap highlights the need to prioritize implementation-focused research to translate predictive accuracy into measurable improvements in clinic efficiency and access.

Hypertension affects about 1.4 billion adults globally and is a major modifiable risk factor for cardiovascular disease. Although several first-line antihypertensive drug classes exist, randomized controlled trials typically report only average treatment effects (ATEs), which mask important variability in individual patient responses. As a result, clinical guidelines often assume a homogeneous patient population, leading to trial-and-error prescribing, delayed blood pressure control, and avoidable adverse effects. I argue that causal forest models combined with double machine learning (DML) enable reliable estimation of heterogeneous treatment effects (HTEs) from observational electronic health record data. These methods can approximate randomized trial validity while capturing clinically meaningful variation in treatment response across patients. Compared with traditional approaches, they are computationally feasible and better suited for individualized treatment assessment. Therefore, comparative effectiveness research in hypertension should move beyond ATE-focused analyses toward routine HTE estimation using causal machine learning. This shift would support more precise, data-driven prescribing and improve patient outcomes.

Medication administration delays are a persistent patient safety and workflow problem in general medical wards. They arise from interacting pressures across nursing workload, pharmacy processes, medication availability, and patient acuity. Current approaches often rely on retrospective incident review, audit reports, or rule-based thresholds after a delay has already occurred. These methods do not provide timely support for proactive workload redistribution or pharmacy escalation. This manuscript proposes a supervised machine learning model to predict the probability that an upcoming scheduled medication dose will be delayed. The model is designed for operational use in general medical ward settings. The proposed model integrates electronic medication administration records, pharmacy dispensing timestamps, nurse-to-patient ratios, and shift-level workload indicators. A gradient boosting framework is conceptually used to capture non-linear relationships among workflow, staffing, and medication availability factors. The model would be expected to identify scheduled doses at elevated risk of delay before the administration window closes. Its outputs could support risk stratification, targeted charge nurse review, and earlier pharmacy coordination. A supervised prediction model for medication administration delay could function as an early warning component within a ward operations dashboard. Such a tool could support proactive clinical operations without replacing nurse judgment.

Hospital workflow analytics has become central to improving throughput, reducing operational cost, and strengthening patient experience. Artificial intelligence offers predictive capabilities for patient flow, staffing, resource use, and delay anticipation. This systematic review examined machine learning models applied to patient flow, staff scheduling, resource utilisation, and operational delay prediction in hospital settings. The review focused on model types, operational endpoints, data sources, validation methods, and implementation maturity. A PRISMA 2020-aligned search strategy was designed for PubMed, Scopus, IEEE Xplore, and Web of Science. Screening, extraction, risk-of-bias appraisal, and narrative synthesis were structured around hospital operations rather than clinical diagnosis. The literature was dominated by retrospective, single-centre studies focused on patient flow, especially length-of-stay, admission, discharge, and bed-use prediction. Staffing, resource utilisation, and operational delay prediction were less frequently studied, and prospective deployment remained uncommon. Machine learning for hospital operations is maturing technically but remains fragmented across isolated workflow domains. Integration across patient flow, staffing, resource utilisation, and delay management requires stronger prospective evaluation.

Hospital discharge delays are costly, disrupt inpatient capacity, and expose patients to avoidable iatrogenic harm. Early identification of patients likely to be ready for discharge could improve patient flow and reduce operational bottlenecks. Current discharge decisions often rely on subjective judgment, fragmented documentation, and sequential review by multiple clinical teams. No single tool routinely integrates the morning snapshot of clinical readiness. This article proposes a predictive model that estimates the probability of same-day discharge readiness by 9 am. The model uses morning laboratory results, active medication orders, vital sign stability, mobility documentation, and pending consultation status. The proposed approach is a supervised classification model using gradient-boosted trees trained on historical inpatient encounters. Features would be assembled from electronic health record data available before morning rounds. Conceptually, the model would generate a calibrated discharge readiness list for clinical review. This list could help care teams focus on borderline patients and support bed-management forecasting. The model could accelerate discharge throughput while maintaining safety by surfacing hidden readiness signals. It is intended to complement, not replace, clinical judgment.

Missed medication doses in long-term care facilities compromise resident safety and arise from intersecting medication, resident, staffing, route, and workload factors. These risks are especially important where residents have complex regimens and high care dependency. Current medication safety approaches in long-term care are often retrospective, audit-based, or broadly applied across all residents. They do not forecast which specific resident–medication pass combinations are most vulnerable before administration occurs. The objective is to describe a predictive model that could estimate the probability of a missed medication dose for each resident–medication pass combination. The model would use medication complexity, resident dependency, staff availability, administration route, and shift-level workload indicators. A supervised classification approach could be trained using electronic medication administration records, staffing rosters, resident assessment data, and medication order characteristics. The model would output a dose-level missed-dose risk score before the relevant medication pass. Conceptually, the model would identify high-risk medication–resident–shift triples and provide an interpretable explanation of dominant risk contributors. For example, the system could flag a non-oral high-risk medication scheduled during a low-staffed morning medication round. Such a model could support proactive prevention by directing nursing attention toward the most vulnerable doses before they are missed. It could also inform shift-level workload planning and safer medication pass organization.

Laboratory alert fatigue erodes the effectiveness of clinical decision support by making repeated abnormal result notifications less likely to prompt timely clinical attention. It is often recognised only after providers begin delaying, overriding, or ignoring alerts. Current alert reduction strategies are commonly based on broad thresholds or blanket suppression rules. These approaches do not explain which providers, specialties, alert types, or repeated result patterns are most susceptible to fatigue. This article proposes an interpretable machine learning model that could predict whether a provider will exhibit fatigued behaviour toward a specific laboratory alert. The model is intended to support transparent, provider-aware alert redesign rather than opaque automation. The proposed framework would use historical alert logs with features capturing alert frequency, clinical severity, provider specialty, repeated abnormal results, response time history, and override behaviour. A regularised logistic regression or gradient-boosted tree model with SHAP explanations would provide both prediction and interpretability. Conceptually, the model would generate a fatigue risk score for each provider–alert pair. It would also attribute the score to specific drivers, such as repeated low-severity results, accumulated alert burden, or recent override patterns. An interpretable fatigue prediction model could enable personalised alert suppression, escalation, or redesign before a clinically important laboratory result is missed. Such a system would support safer, more adaptive clinical decision support.

Blood products are critical hospital resources with demand shaped by elective surgery, trauma, oncology treatment, and ongoing transfusion dependence. Volatility in daily use can create simultaneous risks of shortage and expiry-related wastage. Current inventory management often relies on par-level reordering and manual review of limited indicators. Such approaches may not anticipate daily demand shifts arising from multiple clinical drivers at the same time. This article develops a conceptual predictive model for forecasting daily blood product demand in tertiary hospitals. The model integrates surgical schedules, trauma admission patterns, transfusion history, oncology treatment plans, and inventory depletion data. The proposed approach uses time-series regression or gradient-boosted tree modelling trained on historical transfusion and hospital operations data. The model would output expected demand by blood product type for the next 24 hours. Conceptually, the model would provide a daily product-specific demand forecast with uncertainty bounds. It could flag days of expected high use driven by complex surgical lists, trauma activity, or planned oncology transfusion support. The model could support proactive, data-driven blood inventory management. It may help reduce emergency ordering, improve preparedness, and limit avoidable wastage.

Efficient hospital resource allocation is a persistent operational challenge because demand for beds, staff, equipment, diagnostics, and patient movement changes rapidly. Predictive analytics offers a way to anticipate demand and support more proactive operational decisions. This systematic review synthesised machine learning models applied to hospital resource allocation from 2017 to 2023. The review focused on bed management, staffing demand, equipment use, diagnostic capacity, and patient throughput. A PRISMA 2020-compliant review process was used, including structured searches of PubMed, Scopus, IEEE Xplore, and Web of Science. Screening, extraction, risk-of-bias assessment, and narrative synthesis were conducted to compare model targets, data sources, validation approaches, and implementation maturity. The evidence base was dominated by retrospective studies of patient throughput, emergency department admission prediction, bed demand, and length of stay. Staffing, equipment, and diagnostic capacity forecasting were less frequently represented, while integrated multi-resource command centre models remained uncommon. Machine learning for hospital resource allocation has become technically advanced, but operational translation remains uneven. Most models remained retrospective or locally validated, with limited evidence of prospective deployment, workflow integration, or measurable operational impact.

Revenue cycle inefficiencies, including claim denials, coding errors, delayed reimbursement, and prior authorization workload, impose substantial administrative and financial burdens on healthcare organizations. Machine learning has been proposed as a decision-support approach for improving prediction, automation, and workflow prioritization in these areas. This systematic review examined peer-reviewed and closely related scholarly literature from 2017 to 2023 on machine learning for healthcare revenue cycle analytics. The review focused on claim denial prediction, coding automation, payment delay forecasting, and prior authorization support. A PRISMA 2020-compliant review process was used, including structured database searching, dual screening, and domain-based narrative synthesis. Risk of bias was assessed using criteria adapted from PROBAST-AI, with attention to temporal validation, data leakage, and implementation relevance. The literature showed the greatest maturity in automated clinical coding and emerging but narrower evidence for claim denial prediction. Evidence for payment delay forecasting and prior authorization support was more limited, with few studies describing prospective implementation or measured operational impact. Machine learning shows promise for improving revenue cycle decision support, but most evidence remains retrospective and technically oriented. Deployment is constrained by data fragmentation, explainability requirements, workflow integration, and regulatory caution.

A small fraction of hospital episodes accounts for a disproportionate share of inpatient spending. Early recognition of these episodes remains difficult when risk assessment depends mainly on static admission information. More adaptive prediction is needed to support clinical and financial planning during hospitalization. Existing cost prediction models often emphasize claims, diagnoses, or broad utilization histories while underusing the dynamic signals that emerge during the inpatient stay. Pharmacy utilization, procedure sequencing, length-of-stay progression, and intensive care transfers may reveal escalating resource intensity before the final cost is known. Failure to integrate these modalities limits early identification of high-cost episodes. This article proposes a multimodal deep learning framework for predicting whether a hospitalization could become a high-cost outlier. The model is designed to combine pharmacy utilization, procedure sequences, length-of-stay trends, intensive care transfer events, and administrative claims data. The intended use is dynamic risk estimation early and repeatedly during the episode. The conceptual model uses separate modality-specific encoders for static claims features, temporal procedure events, pharmacy utilization patterns, length-of-stay trajectories, and intensive care transfer indicators. These representations are fused into a shared episode-level embedding trained with a cost-sensitive objective. The framework is intended for evaluation in historical and silent prospective deployment settings without assuming immediate clinical intervention effects. Conceptually, the model would output an updated probability that an active hospitalization will exceed a high-cost threshold. This probability would change as new medication orders, procedures, length-of-stay milestones, and intensive care transfers occur. The output could support utilization review, case management, pharmacy stewardship, and financial counseling workflows. A multimodal deep learning model for high-cost hospital episode prediction could help health systems identify emerging cost outliers before discharge. By combining static claims information with dynamic inpatient trajectories, such a model could support earlier resource allocation and more coordinated care planning. Its value should be assessed through careful validation, calibration, workflow integration, and prospective impact evaluation.

Clinical pathways are designed to standardize inpatient care for common conditions while allowing clinically justified individualization. Deviations from these pathways are frequent and may reflect either appropriate adaptation to patient complexity or potentially harmful departure from evidence-informed practice. Current deviation detection often depends on retrospective audit, static compliance rules, or aggregate dashboards. These approaches can miss subtle temporal drift in care delivery and rarely explain why a specific patient trajectory diverged from the expected pathway. This article proposes an interpretable machine learning model for detecting clinical pathway deviations in hospitalized patients. The model focuses on order sequences, vital sign trends, laboratory monitoring frequency, and provider decision patterns as dynamic indicators of care-process variation. Conceptually, the model would compare each patient’s evolving care trajectory with learned expected pathways using sequence-comparison and outlier-detection logic. SHAP-based or attention-informed explanations would identify the specific features responsible for a deviation flag, such as delayed monitoring, omitted follow-up testing, or unusual ordering behavior. The proposed model could detect when a patient’s care trajectory diverges from an expected pathway and provide a transparent rationale for review. For example, it could flag a missing repeat troponin, a delayed antibiotic escalation, or a laboratory monitoring pattern inconsistent with the patient’s clinical state. An interpretable pathway-deviation model could shift quality monitoring from manual, sample-based review toward continuous and transparent pathway surveillance. Such a system would support real-time clinical awareness, structured audit, and organizational learning.

Emergency admissions frequently wait for inpatient bed placement when hospital capacity, infection control needs, staffing limitations, and specialty-bed requirements collide. These delays can prolong emergency department boarding and disrupt hospital-wide patient flow. Current bed management is often reactive, relying on bed coordinators, charge nurses, manual communication, and local escalation routines. Without a prospective warning system, teams may recognize an impending placement delay only after the admission queue has already stalled. The objective is to develop a machine learning model that predicts, at the time of admission decision, whether a patient is likely to experience delayed placement beyond a defined operational threshold. The model would use bed assignment logs, isolation requirements, unit census, nurse staffing levels, and specialty service availability as core predictors. A supervised classification model based on gradient-boosted trees would be trained on historical emergency admissions and linked operational data. The model would generate a placement delay risk score that can be refreshed as bed status, staffing, and unit conditions change. Conceptually, the model would identify admissions at elevated risk for delayed placement and attribute risk to operational constraints such as limited isolation rooms, high census, low staffing, or unavailable specialty beds. These explanations would give bed managers lead time to intervene before the delay becomes entrenched. This predictive model could shift hospital bed management from a reactive queue-based process to proactive, data-driven placement coordination. It would support earlier escalation, more targeted resource allocation, and improved alignment between emergency admissions and inpatient capacity.